ReviewAmerican journal of clinical dermatology2024
Chronic Hand Eczema.
Review in American journal of clinical dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07286487 (Effects of Glycyrrhetinic Acid on Human Skin in an Acute Irritant Contact Dermatitis Model), which is not on this map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Glycyrrhetinic Acid on Human Skin in an Acute Irritant Contact Dermatitis Model
Who cites it
19 citing papers in PubMed.
- Hand Eczema Referred for Patch Testing: Retrospective Study in Shanghai, China From 2018 to 2023.The Journal of dermatology · 2026Article
- Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment.Dermatology and therapy · 2026Article
- [New diagnostic possibilities in hand eczema].Dermatologie (Heidelberg, Germany) · 2026Review
- Real-Life Workup of Chronic Hand Eczema Using a Dedicated Case Report Form: A SIDAPA Multicentre Study.Contact dermatitis · 2026Article
- Treatment Patterns and Economic Burden in Moderate to Severe Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis.Dermatology and therapy · 2026Article
- A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand Eczema.Dermatology and therapy · 2026Article
- Molecular Diagnostics in Hand Dermatoses: Clinical Findings and Health-Related Quality of Life in a 3-Year Follow-Up Cohort Study.Dermatology and therapy · 2026Article
- [Allergy or atopy-occupational dermatitis is often more complex than initially thought].Dermatologie (Heidelberg, Germany) · 2026Article
- Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States.American journal of clinical dermatology · 2026Review
- Molecular Classification in a Cohort of Occupational Dermatological Patients: Diagnostic Results and Course of Ability to Work and Sick Leave Over Two Years.Acta dermato-venereologica · 2026Article
- Review
- Stress perception of occupational dermatology patients: a qualitative interview study.Frontiers in public health · 2026Article
- Comparative Efficacy of Monotherapies for Chronic Hand Eczema: A Network Meta-Analysis Study.Journal of cosmetic dermatology · 2025Article
- Psychological Cofactors in Occupational Skin Diseases: Results of a Systematic Literature Search.Acta dermato-venereologica · 2025Article
- Efficacy and Safety of Runzaozhiyang Lotion for Chronic Hand Eczema: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2025Article
- Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Article
- A Practical Approach to Chronic Hand Eczema.Dermatology and therapy · 2025Article
- Chronic Hand Eczema (CHE): A Narrative Review.Dermatology and therapy · 2025Review
- Italian Expert Opinion on Chronic Hand Eczema: from Guidelines to Clinical Practice.Dermatology and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic hand eczema (CHE) is a complex, challenging, and frequently multifactorial skin disease of the hands. It is very common in the general population, especially in certain professions. When hand eczema (HE) persists for longer than 3 months or has a minimum of two relapses per year after initial manifestation with complete clearance, it is considered chronic. In this case, health-related quality of life and the patient's working life are often impaired. CHE can be considered as an umbrella term because it covers different clinical pictures and etiologies. To date, there is no definite and unique HE classification. Treatment starts with identifying the individual HE etiology paralleled by symptomatic therapy (local and/or systemic and/or ultraviolet phototherapy). Sustainable management of HE requires the identification and avoidance of its triggering factors, from the professional and private environment. This includes ruling out allergic contact dermatitis if any HE persists for more than 3 months despite adequate therapy. Randomized controlled trials investigating the efficacy in HE are lacking for several treatment modalities. Patient education measures of skin protection and prevention complete the multimodal treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.